CollPlant Biotechnologies Ltd

CLGN

Exchange: Nasdaq
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK: 0001631487

SEC filings (opens in a new tab)

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding CollPlant Biotechnologies Ltd changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of CLGN: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	18	17	−1
Shares	1.53M	1.43M	−97.3K (−6.4%)
Value	$8.55M	$9.14M	+$591.5K (+6.9%)

New holders (2)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to CLGN in Q4 2023
Institution	Shares	Value	% of portfolio
Citadel Advisors LLC	6,734	$43.0K	0.00%
JPMorgan Chase & Co	371	$2.37K	0.00%

Sold out (3)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of CLGN in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
UBS Group AG	5,690	$31.7K
Geneos Wealth Management Inc.	750	$4.22K
Simplex Trading, LLC	100	$0